Shanghai Pharmaceuticals Holding Co Ltd

Return on Assets, %

2.4

2.4

Net income margin, %

1.3

1.5

EBITDA margin, %

3.8

4.6

Debt to Equity, %

90.2

35.4

Intangible assets and goodwill, %

8.3

1.8

Revenue CAGR 3Y, %

10.6

8.3

Total Equity change 1Y, %

-0.8

0

Revenue Y, % chg

6.4

1.5

P/E

16.3

17.4

P/BV

0.9

1.2

P/S

0.2

0.6

EV/S

0.3

0.8

EV/EBITDA

10.3

8.6

Average Analyst recommendation

Buy

Buy

Average upside forecasts, %

-58.4

20.7

Forward P/E

10.7

13.1

Dividend Yield, %

6

2.7

Forward Dividend Yield, %

1.2

0.5

Expected dividend per share

0

0.1

Payout Ratio, %

40.2

30.7

Dividend Ex Date

2023-07-17